|
Feb 21
|
Charles River Laboratories International Full Year 2024 Earnings: EPS Misses Expectations
|
|
Feb 20
|
Charles River Laboratories International Inc (CRL) Q4 2024 Earnings Call Highlights: Navigating ...
|
|
Feb 20
|
Q4 2024 Charles River Laboratories International Inc Earnings Call
|
|
Feb 19
|
Analyst Sees Charles River As Preclinical Leader But Maintains Neutral Stance
|
|
Feb 19
|
CRL Stock Up on Q4 Earnings and Revenue Beat, Margins Fall
|
|
Feb 19
|
Compared to Estimates, Charles River (CRL) Q4 Earnings: A Look at Key Metrics
|
|
Feb 19
|
Charles River beats quarterly estimates on stable demand for drug development services
|
|
Feb 19
|
Charles River Laboratories (CRL) Tops Q4 Earnings and Revenue Estimates
|
|
Feb 19
|
Charles River Laboratories (NYSE:CRL) Posts Better-Than-Expected Sales In Q4
|
|
Feb 19
|
Charles River: Q4 Earnings Snapshot
|
|
Feb 19
|
Charles River Laboratories Announces Fourth-Quarter and Full-Year 2024 Results and Provides 2025 Guidance
|
|
Feb 18
|
Earnings To Watch: Charles River Laboratories (CRL) Reports Q4 Results Tomorrow
|
|
Feb 17
|
Gear Up for Charles River (CRL) Q4 Earnings: Wall Street Estimates for Key Metrics
|
|
Jan 2
|
Should You Retain Charles River Stock in Your Portfolio Now?
|